- Home
- RGNX vs HTT Comparison
RGNX vs HTT Comparison
Compare RGNX & HTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RGNX | HTT |
|---|---|---|
| Founded | 2008 | 2014 |
| Country | United States | China |
| Employees | N/A | 101 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 528.6M | 464.3M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | RGNX | HTT |
|---|---|---|
| Price | $8.04 | $3.08 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $28.75 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 433.9K |
| Earning Date | 05-05-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.08 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,393,000.00 | N/A |
| Revenue This Year | $51.21 | N/A |
| Revenue Next Year | $19.08 | N/A |
| P/E Ratio | ★ N/A | $4.14 |
| Revenue Growth | ★ 126.48 | N/A |
| 52 Week Low | $5.46 | $1.88 |
| 52 Week High | $16.19 | $3.91 |
Technical Indicators
Market Signals| Indicator | RGNX | HTT |
|---|---|---|
| Relative Strength Index (RSI) | 56.93 | 75.01 |
| Support Level | $5.67 | $2.97 |
| Resistance Level | $9.88 | $3.16 |
| Average True Range (ATR) | 0.57 | 0.06 |
| MACD | 0.24 | 0.00 |
| Stochastic Oscillator | 67.37 | 87.50 |
Price Performance
Historical ComparisonAbout RGNX REGENXBIO Inc.
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
About HTT High Templar Tech Limited American depositary shares each representing one Class A ordinary share
High Templar Tech Ltd is an enabler of financial technology. High Templar is focusing on exploring business opportunities globally to satisfy clients' demand by leveraging its technology know-how and financial service capabilities. The company focus empowering financial institutions with its technological capabilities, helping them improve marketing and operational efficiency and efficiently connect their diverse financial products with online traffic.